PureHealth has signed an agreement to acquire Circle Health Group, the UK's largest
independent operators of hospitals, in a deal valued at AED 4.41 billion. PureHealth has
signed an agreement to
acquire Circle Health Group,
the UK's largest independent
operators of hospitals, in a
deal valued at AED 4.41
billion.
Circle Health Group joins a
roster of world-class
healthcare providers that make up PureHealth companies, including
SEHA - Abu Dhabi Health Services Company; Daman - Nation Health
Insurance Co.; PureLab - which is the Gulf Cooperation Council's largest
lab network; Rafed - Group Procurement Organisation; and Abu Dhabi
Stem Cells Centre, which leads cutting-edge stem cell research.PureHealth is the largest healthcare group in the Middle East and this
acquisition underlines PureHealth's commitment to delivering worldclass medical care to patients globally, as well as developing new clinical care pathways made up of the best healthcare providers to meet patient
needs.
PureHealth aims to invest in scientific innovation and healthcare
infrastructure within all its assets, including Circle Health Group, giving
access to patients around the world to the best possible medical care
with the highest international quality standards, leading them to live
longer, healthier and happier lives The acquisition of Circle Health Group is PureHealth's first entry into
the UK. This acquisition forms part of PureHealth's global expansion
programme, which includes acquisitions previously completed in the US,
as well as entry in other international markets. Patients in the UAE and
the UK will benefit from PureHealth's acquisition, both through the
diversity of choice in healthcare provision, expanded network of medical
professionals and expertise combined with knowledge sharing that will
be developed.
Circle Health Group offers the UK's largest national network of private
hospitals. It also offers innovative neurological and musculoskeletal
rehabilitation services and pathway management services and is the first
European healthcare provider to enter the Chinese market.